Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Joseph Neimat

Neurological Surgery Louisville, KY Medical Doctor

NPI 1417984329 CMS profile 245384

220 Abraham Flexner Way Ste 1200, Louisville, KY 40202

Open in the dashboard

General payments

$196,192

293 records reported · program years 2019–2025

Research payments

$96,506

Paid to them · 183 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$195,615 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Joseph Neimat of Louisville, KY is reported in the CMS Open Payments database as having received $196,192 across 293 general payments and $96,506 in research payments paid to them. Separately, studies naming them as principal investigator received $195,615 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 95th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $23,511 54
2025 Research $58,916 93
2024 General $19,620 38
2024 Research $7,141 43
2023 General $28,285 38
2023 Research $30,249 46
2022 General $38,120 56
2022 Research $200 1
2021 General $18,896 32
2020 General $8,590 19
2019 General $59,170 56

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Joseph Neimat
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Joseph Neimat were reported at $23,511. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Joseph Neimat Neurological Surgery median Middle half National median
2019 $59,170 $582 $138–$3,006 $163
2020 $8,590 $294 $76–$2,174 $114
2021 $18,896 $387 $105–$2,432 $132
2022 $38,120 $542 $139–$2,989 $149
2023 $28,285 $534 $145–$2,697 $160
2024 $19,620 $574 $155–$3,046 $164
2025 $23,511 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Monteris Medical Corporation $68,856 87 payments
  2. Abbott Laboratories $39,532 48 payments
  3. Accuray Incorporated $22,562 27 payments
  4. Boston Scientific Corporation $20,992 37 payments
  5. Medtronic, Inc. $17,091 30 payments
  6. Medtronic USA, Inc. $10,685 14 payments
  7. FHC, Inc. $10,291 2 payments
  8. Globus Medical, Inc. $1,929 12 payments
  9. NeuroPace, Inc. $1,060 10 payments
  10. DIXI Medical USA Corp $832 2 payments
  11. Other $2,363 24 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $137,015 65 payments
  2. Travel and Lodging $27,316 82 payments
  3. Food and Beverage $11,849 139 payments
  4. Compensation for serving as faculty or as a speaker for a medical education program $10,291 2 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $6,721 4 payments
  6. Honoraria $3,000 1 payment
Products named General payments · program years 2019–2025
  1. Neuroblate NeuroBlate $62,456 83 payments
  2. Neuromodulation Dspsbls and Accs $19,351 14 payments
  3. GENERAL DBS $16,738 7 payments
  4. TomoTherapy System $16,510 22 payments
  5. CyberKnife System $16,510 22 payments
  6. INFINITY $10,907 10 payments
  7. StealthStation $10,132 6 payments
  8. VISUALASE $9,875 13 payments
  9. NeuroBlate NeuroBlate $6,400 4 payments
  10. Stealth Autoguide $6,262 7 payments
  11. Other $27,455 116 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. NeuroPace, Inc. $96,306 182 payments
  2. Monteris Medical Corporation $200 1 payment

Billing to Medicare

Part B · data year 2024 · 27 billing codes

Paid by Medicare

$46,823

Medicare's payments for the services billed

Medicare patients

44

Average age 70

Services billed

87

14 women, 30 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 48%
Depression 43%
Diabetes 32%
Chronic kidney disease 30%
Ischemic heart disease 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

476 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record